Search

everythinglearnresearchcommunity

for

Search:↓

Married women with type 2 diabetes had a surprisingly low infertility rate, suggesting type 2 diabetes and PCOS may be different conditions.

Type-2 immunity may influence skin diseases and could be targeted for treatment.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Wnt-signaling is regulated differently in skin cells and immune responses during wound healing.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Disrupting Acvr1b in mice causes severe hair loss and thicker skin.

ESR2 gene linked to female-pattern hair loss.

Higher levels of the DP2 receptor may lead to hair loss.

Scientists made a chemical (compound 4e) that can be applied on skin to reduce oil production, which can help with acne, but it might cause skin sensitivity to light.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

NKG2D gene polymorphism doesn't affect SLE risk but may influence symptoms like rash and hair loss.

Nicotinic acid reduces excessive oil production in skin cells by activating a specific receptor, which could help treat acne.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

GRK2 is essential for healthy hair follicle function, and its absence can lead to hair loss and cysts.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Glycemic control medications for Type 2 diabetes can affect skin conditions like psoriasis.

A mutation in the EDNRA gene causes Oro-Oto-Cardiac syndrome, affecting face and heart development.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

Gene differences may affect baldness treatment response in Korean men.

Dihydrotestosterone treatment can help penis growth in boys with 5α-reductase deficiency but doesn't fully normalize size after puberty.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

17β-estradiol lowers polyamine oxidase levels in breast cancer cells through estrogen receptor 2.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.